RTI Surgical (RTIX) Receiving Somewhat Favorable News Coverage, Report Finds
Headlines about RTI Surgical (NASDAQ:RTIX) have trended somewhat positive this week, according to Accern. Accern scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. RTI Surgical earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned news headlines about the medical equipment provider an impact score of 46.4471646228182 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
These are some of the news headlines that may have impacted Accern’s scoring:
- $66.27 Million in Sales Expected for RTI Surgical, Inc. (RTIX) This Quarter (americanbankingnews.com)
- RTI Surgical, Inc. (RTIX) Director Acquires $25,850.00 in Stock (americanbankingnews.com)
- Keep Your Eyes on Hot stock of yesterday-: Agilent Technologies, Inc. (A) (wisdomsave.com)
- North America Sports Medicine Market Worth USD 14.4 Billion by 2024 | CAGR of 7.8% (medgadget.com)
- Whatever you do, don’t take a selfie with the solar eclipse (techkenyot.com)
RTIX has been the topic of several research analyst reports. Zacks Investment Research cut RTI Surgical from a “hold” rating to a “sell” rating in a research note on Wednesday, May 3rd. TheStreet raised RTI Surgical from a “d+” rating to a “c-” rating in a report on Friday, May 5th. ValuEngine raised RTI Surgical from a “sell” rating to a “hold” rating in a report on Friday, June 2nd. Finally, BidaskClub lowered RTI Surgical from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th.
Shares of RTI Surgical (NASDAQ RTIX) remained flat at $4.55 during midday trading on Friday. The stock had a trading volume of 226,673 shares. The firm’s 50 day moving average price is $5.33 and its 200-day moving average price is $4.60. RTI Surgical has a 12-month low of $2.50 and a 12-month high of $6.00. The firm’s market cap is $268.60 million.
RTI Surgical (NASDAQ:RTIX) last released its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.02 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.02. The business had revenue of $72.10 million during the quarter, compared to the consensus estimate of $70.25 million. RTI Surgical had a positive return on equity of 2.07% and a negative net margin of 6.53%. The company’s revenue for the quarter was up 6.7% compared to the same quarter last year. On average, equities analysts anticipate that RTI Surgical will post $0.06 EPS for the current year.
In other RTI Surgical news, EVP John N. Varela bought 12,000 shares of the business’s stock in a transaction dated Friday, August 11th. The shares were purchased at an average price of $4.85 per share, for a total transaction of $58,200.00. Following the purchase, the executive vice president now directly owns 47,998 shares of the company’s stock, valued at $232,790.30. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Nicholas J. Valeriani bought 5,500 shares of the business’s stock in a transaction dated Monday, August 21st. The stock was acquired at an average price of $4.70 per share, for a total transaction of $25,850.00. Following the purchase, the director now directly owns 47,754 shares in the company, valued at $224,443.80. The disclosure for this purchase can be found here. 4.90% of the stock is currently owned by insiders.
WARNING: “RTI Surgical (RTIX) Receiving Somewhat Favorable News Coverage, Report Finds” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/08/25/rti-surgical-rtix-receiving-somewhat-favorable-news-coverage-report-finds.html.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Stock Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related stocks with our FREE daily email newsletter.